Stopped: Administrative Reasons
The purpose of this study is to evaluate the safety and potential of a new experimental imaging instrument called multispectral optoacoustic tomography (MSOT) to detect inflammation in patients with chronic graft versus host disease of the skin or GI tract, Crohn's disease, or Colitis disease.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Adverse Events due to MSOT imaging post enrollment.
Timeframe: 5 minutes for an MSOT image (up to 48 hours post-image)
Adverse Events due to MSOT imaging 4 weeks after treatment.
Timeframe: 5 minutes for an MSOT image (up to 48 hours post-image)
Measurement of skin temperature before first MSOT image post enrollment.
Timeframe: 1-2 minutes before the MSOT image.
Measurement of skin temperature after first MSOT image post enrollment.
Timeframe: 1-2 minutes after the MSOT image.
Measurement of skin temperature before second MSOT image post-treatment.
Timeframe: 1-2 minutes before the MSOT image.
Measurement of skin temperature after second MSOT image post-treatment.
Timeframe: 1-2 minutes after the MSOT image.